chr5-138466963-T-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001964.3(EGR1):āc.514T>Gā(p.Ser172Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000886 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001964.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
EGR1 | NM_001964.3 | c.514T>G | p.Ser172Ala | missense_variant | 2/2 | ENST00000239938.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
EGR1 | ENST00000239938.5 | c.514T>G | p.Ser172Ala | missense_variant | 2/2 | 1 | NM_001964.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 151998Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000756 AC: 19AN: 251364Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135858
GnomAD4 exome AF: 0.0000889 AC: 130AN: 1461834Hom.: 0 Cov.: 33 AF XY: 0.0000866 AC XY: 63AN XY: 727216
GnomAD4 genome AF: 0.0000855 AC: 13AN: 151998Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | The c.514T>G (p.S172A) alteration is located in exon 2 (coding exon 2) of the EGR1 gene. This alteration results from a T to G substitution at nucleotide position 514, causing the serine (S) at amino acid position 172 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at